Martha Morrell - Mar 24, 2025 Form 4 Insider Report for NeuroPace Inc (NPCE)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Leah Akin, Attorney-in-Fact
Stock symbol
NPCE
Transactions as of
Mar 24, 2025
Transactions value $
$0
Form type
4
Date filed
3/24/2025, 06:10 PM
Previous filing
Mar 5, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NPCE Common Stock Award $0 +11.7K +14.77% $0.00 90.9K Mar 24, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NPCE Stock Option (Right to Buy) Award $0 +19.9K $0.00 19.9K Mar 24, 2025 Common Stock 19.9K $12.30 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on March 24, 2026 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter.
F2 25% of the shares subject to the option vest on March 24, 2026. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter.